skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:064102/0263   Pages: 12
Recorded: 06/28/2023
Attorney Dkt #:340080.01658
Conveyance: SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 6
1
Patent #:
NONE
Issue Dt:
Application #:
10653397
Filing Dt:
09/02/2003
Publication #:
Pub Dt:
03/03/2005
Title:
Medical device for reduction of pressure effects of cardiac tricuspid valve regurgitation
2
Patent #:
Issue Dt:
01/24/2017
Application #:
13571044
Filing Dt:
08/09/2012
Publication #:
Pub Dt:
02/14/2013
Title:
VIAL USEABLE IN TISSUE EXTRACTION PROCEDURES
3
Patent #:
NONE
Issue Dt:
Application #:
16738870
Filing Dt:
01/09/2020
Publication #:
Pub Dt:
12/10/2020
Title:
VIABLE CELL COMPOSITIONS, AND METHODS RELATED TO SAME
4
Patent #:
NONE
Issue Dt:
Application #:
17302633
Filing Dt:
05/07/2021
Publication #:
Pub Dt:
08/19/2021
Title:
USES OF TREHALOSE IN CELL SUSPENSIONS
5
Patent #:
NONE
Issue Dt:
Application #:
17302747
Filing Dt:
05/11/2021
Publication #:
Pub Dt:
03/31/2022
Title:
SYSTEMIC, ALLOGENIC STEM CELL THERAPIES FOR TREATMENT OF DISEASES IN ANIMALS
6
Patent #:
NONE
Issue Dt:
Application #:
17498683
Filing Dt:
10/11/2021
Publication #:
Pub Dt:
08/04/2022
Title:
MESENCHYMAL STEM CELLS FOR ORAL INFLAMMATION TREATMENT
Assignor
1
Exec Dt:
06/23/2023
Assignee
1
104 LA MESA DRIVE, SUITE 102
PORTOLA VALLEY, CALIFORNIA 94028
Correspondence name and address
JEFFREY T. KLUGMAN
345 CALIOFORNIA STREET
SUITE 2200
SAN FRANCISCO, CA 94104

Search Results as of: 06/30/2024 01:51 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT